Selective enhancement of multipotential hematopoietic progenitors in vitro and in vivo by IL-20

Blood. 2003 Nov 1;102(9):3206-9. doi: 10.1182/blood-2003-05-1419. Epub 2003 Jul 10.

Abstract

In a search for novel growth factors, we discovered that human interleukin-20 (IL-20) enhanced colony formation by CD34+ multipotential progenitors. IL-20 had no effect on erythroid, granulocyte-macrophage, or megakaryocyte progenitors. IL-20 transgenic mice increased the numbers and cell cycling of multipotential but not other progenitors. IL-20 administration to normal mice significantly increased only multipotential progenitor cells, demonstrating that IL-20 significantly influences hematopoiesis, with specificity toward multipotential progenitors. This is the first cytokine with such specificity identified.

MeSH terms

  • Animals
  • Antigens, CD34
  • Bone Marrow Cells / cytology
  • Cell Division / drug effects
  • Cells, Cultured
  • Fetal Blood / cytology
  • Hematopoiesis / drug effects
  • Hematopoietic Stem Cells / cytology*
  • Hematopoietic Stem Cells / drug effects
  • Humans
  • Interleukins / administration & dosage
  • Interleukins / pharmacology*
  • Mice
  • Mice, Transgenic
  • Multipotent Stem Cells / cytology
  • Multipotent Stem Cells / drug effects*

Substances

  • Antigens, CD34
  • Interleukins
  • interleukin 20